Upload
rajatsingla
View
219
Download
0
Embed Size (px)
Citation preview
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
1/36
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
2/36
RATIO ANALYSIS
FOR
SUN PHARMACEUTICALS LIMITED
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
3/36
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
4/36
SUN PHARMACEUTICAL LIMITED
Balace Sheet (Figurs in Crores)Mar '05 Mar '06 Mar '07 Mar '08 Mar '09
12 mths 12 mths
Sources Of Funds
Total Share Capital 94.16 94.27 98.07 103.56 103.56
Equity Share Capital 92.76 92.87 96.7 103.56 103.56
0.01 0 0 0 0
1.4 1.4 1.37 0 0
Reserves
0 0 0 0 0
Networth
Secured Loans 13.92 18.23 20.39 22.88 23.6
Unsecured Loans 79.64 0
Total Debt 102.52 23.6
Total Liabilities
Mar '05 Mar '06 Mar '07 Mar '08 Mar '09
12 mths 12 mths
Application Of Funds
Gross Block 612.05 744.26 838.7 935.03
172.9 208.07 249.41 304.99 362.64
Net Block 439.15 536.19 589.29 630.04 699.26
47.94 30.8 33.43 75.95
Investments 985.24 779.62
mths
mths
mths
are pp ca onMoney
Capital
1,011.28
1,370.67
2,351.42
4,104.06
5,047.86
Reserves
, .5
, .4
, .9
, .2
, .2
3 9 6
, .5 , .2 , .5, .
0, .
6, .
4, .
4, .
2
mths
mths
mths
, .0
.Depreciation
Capital Work inProgress
1,057.49
1,843.57
2,694.59
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
5/36
Inventories 186.62 263.41 333.38 389.63 486.74
Sundry Debtors 234.97 256.47 310 680.03
4.01 11.26 35.69 23.29 20.17
Total Current Assets 425.6 531.14 679.07
Loans and Advances 445.55 509.25 345.82 394.13 311.42Fixed Deposits 886.02
Deffered Credit 0 0 0 0 0
Current Liabilities 224.95 273.3 345.23 845.73 696.34
Provisions 84.45 122.5 7.7 262.79 342.1
309.4 395.8 352.93
Net Current Assets
0 0 0 0 0
Total Assets
39.77 39.76 107.62 72.08 85.36
Book Value (Rs) 59.51 78.8 126.58 203.15 248.72
1,055.44
Cash and BankBalance
6 4
6 9 3 0
Total CA, Loans &Advances
1,757.17
2,259.95
2,191.88
2,911.62
2,743.66
Total CL &Provisions
1,108.52
1,038.44
7 5 5 0 2
Expenses, .
0, .
6, .
4, .
4, .
2
Liabilities
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
6/36
Mar '05 Mar '06 Mar '07 Mar '08
12 mths 12 mths 12 mths 12 mths
IncomeSales Turnover 1056.01 1353.01 1722.13 2427.35
Excise Duty 48.73 61.37 59.57 58.84
Net Sales 1007.28 1291.64 1662.56 2368.51
Other Income 232.87 525.55 750.26 914.83
Stock Adjustments -0.45 57.23 41.41 17.38
Total Income 1239.7 1874.42 2454.23 3300.72
Expenditure
Raw Materials 563.75 899.67 1214.48 1564.61
Power & Fuel Cost 14.48 25.55 31.14 37.36
Employee Cost 82.78 82.01 98.87 120.2Other Manufacturing Expe 24.97 23.11 25.08 35.21
Selling and Admin Expens 163.72 287.47 370.2 415.35
Miscellaneous Expenses 37.1 15.97 18.85 14.62
Preoperative Exp Capitalis 0 0 0 0
Total Expenses 886.8 1333.78 1758.62 2187.35
Mar '05 Mar '06 Mar '07 Mar '08
12 mths 12 mths 12 mths 12 mths
Operating Profit 120.03 15.09 -54.65 198.54
PBDIT 352.9 540.64 695.61 1113.37
Interest 0 11.23 8.8 5.06
PBDT 352.9 529.41 686.81 1108.31
Depreciation 32.83 40.73 46.27 56.11
Other Written Off 2.45 0 0 0
Profit Before Tax 317.62 488.68 640.54 1052.2
Extra-ordinary items 12.45 0 -0.05 0
PBT (Post Extra-ord Items) 330.07 488.68 640.49 1052.2
Tax 17.77 27.39 11.61 38.16Reported Net Profit 305.71 461.29 628.93 1014.04
Total Value Addition 323.05 434.11 544.14 622.74
Preference Dividend 0.08 0.08 0.08 0.05
Equity Dividend 69.57 102.3 130.01 217.47
Corporate Dividend Tax 9.91 14.36 18.25 37.2
Per share data (annualised)
Shares in issue (lakhs) 1855.11 1857.32 1934.02 2071.16
Earning Per Share (Rs) 16.48 24.83 32.52 48.96
PROFIT AND LOSS STATEMENTS (FIG IN CROR
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
7/36
Equity Dividend (%) 75 110 135 210
Book Value (Rs) 59.51 78.8 126.58 203.15
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
8/36
Mar '09
12 mths
2833.65
59
2774.65
1276.22
23.78
4074.65
1961.89
50.44
148.3143.93
494.98
18.06
0
2717.61
Mar '09
12 mths
80.82
1357.04
2.77
1354.27
58.86
0
1295.41
11.7
1307.11
30.121265.29
755.72
0
284.79
48.4
2071.16
61.09
ES)
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
9/36
275
248.72
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
10/36
RATIO ANALYSIS
Short term liquidityCurrent ratioMar '05 Mar '06 Mar '07 Mar '08
Current assets 425.6 531.14 679.07 1,468.36
/ Current liabilities224.95 273.3 345.23 845.73
= Current ratio
1.89 1.94 1.97 1.74
Quick ratio (Acid Test) Mar'05 Mar'06 Mar'07 Mar'08
(Cash 4 11 36 23.29
+ Marketable secrities - - - -
+ Accounts receivable) 235 256 310 1,055
/ Current liabilities 224.95 273.3 345.23 845.73
= Quick ratio 1.06 0.98 1.00 1.28
Mar'05 Mar'06 Mar'07 Mar'08
Annual net credit sales 1,007.28 1,291.64 1,662.56 2,368.51
234.97 256.47 310 1,055.44
4.29 5.04 5.36 2.24
Mar'05 Mar'06 Mar'07 Mar'08
365 days 365 365 365 365
4.29 5.04 5.36 2.24
85.14 72.47 68.06 162.65
Inventory turnover Mar'05 Mar'06 Mar'07 Mar'08
Measures the ability to paycurrent liabilities out of current
Measures the ability to paycurrent liabilities out of themost liquid of current assets.
3.Accounts receivableturnover
Measures the ability to collectfrom customers.
/ Average net accountreceivables
= Accounts receivable
4.Average collection period(Days Sales Outstanding)
Measures the average numberof day that it takes to collectaccounts receivable.
/ Accounts receivable
= Average collection period(Days Sales Outstanding)
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
11/36
Net sales 1,007.28 1,291.64 1,662.56 2,368.51
/ Average inventory 186.62 263.41 333.38 389.63
= Inventory turnover 5.4 4.9 4.99 6.08
Days sales in inventory Mar'05 Mar'06 Mar'07 Mar'08
365 days 365 365 365 365
/ Inventory turnover 5.4 4.9 4.99 6.08
Days sale in inventory 67.62 74.44 73.19 60.04
Debt ratio Mar'05 Mar'06 Mar'07 Mar'08
Total liabilities 309.40 2,259.95 679.07 1,468.36
/ Total assets 2,920.10 3,210.76 3,517.64 4,310.14
= Debt ratio 0.11 0.70 0.19 0.34
Mar'05 Mar'06 Mar'07 Mar'08
320.07 499.91 649.34 1,057.26
/ Interest expense 0 11.23 8.8 5.06
44.52 73.79 208.94
Total asstes to equity Mar'05 Mar'06 Mar'07 Mar'08
Total assets 2,920.10 3,210.76 3,517.64 4,310.14
/ Total stockholders equity 94.16 94.27 98.07 103.56
= Total assets to equity 31.01 34.06 35.87 41.62
Mar'05 Mar'06 Mar'07 Mar'08
Total liabilities 309.40 2,259.95 679.07 1,468.36
/ Total assets 2,920.10 3,210.76 3,517.64 4,310.14
0.11 0.70 0.19 0.34
Measures the saleability ofinventory. Indicates thenumber of time inventory issold or "turned" per year.
Measures inventory levelsbased on days sales.
L O N G T E R M
S O L V E N C Y R A T I O S
Indicates the percentage ofassets financed with debt orliabilities
Times interest earned -income (interest coverage)
Measures the ability to payinterest out of profits.
Net income before interestexpense and taxes
= Times interest earned -income (interest coverage)
Total liabilities to total
= Total liabilities to total
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
12/36
Total liabilities to equity Mar'05 Mar'06 Mar'07 Mar'08
Total liabilities 309.40 2,259.95 679.07 1,468.36
/ Total stockholders equity 94.16 94.27 98.07 103.56
= Total liabilities to equity 3.29 23.97 6.92 14.18
DEBT-EQUITY RATIO Mar'05 Mar'06 Mar'07 Mar'08
Outsiders Fund 2,039.60 2,019.12 1,413.38 948.25
Total shareholders fund 1,105.44 1,464.94 2,449.49 4,207.62
D/E ratio 1.85 1.38 0.58 0.23
Propreitory Equity ratio Mar'05 Mar'06 Mar'07 Mar'08
Shareholder fund 2,812.01 3,098.26 3,399.18 4,183.70
/Total Assets 309.40 2,259.95 679.07 1,468.36
Propreitory Equity ratio 9.09 1.37 5.01 2.85
PROFITABILITY RATIOS
Return on assets Mar'05 Mar'06 Mar'07 Mar'08
Net income 305.71 461.29 628.93 1,014.04
/ Average total assets 309.40 2,259.95 679.07 1,468.36
= Return on assets 0.99 0.2 0.93 0.69
Return on equity Mar'05 Mar'06 Mar'07 Mar'08
Net income 305.71 461.29 628.93 1,014.04
/ Average stockholders equity 94.16 94.27 98.07 103.56
= Return on equity 3.25 4.89 6.41 9.79
Gross margin Mar'05 Mar'06 Mar'07 Mar'08
Gross profit 321.30 261.30 292.99 611.13
/ Sales 1,007.28 1,291.64 1,662.56 2,368.51
= Gross margin % 0.32 0.2 0.18 0.26
Operating margin Mar'05 Mar'06 Mar'07 Mar'08Operating profit 120.03 15.09 -54.65 198.54
/ Sales 1,007.28 1,291.64 1,662.56 2,368.51
= Operating margin 0.12 0.01 -0.03 0.08
Profit margin Mar'05 Mar'06 Mar'07 Mar'08
Net income 305.71 461.29 628.93 1,014.04
/ Sales 1,007.28 1,291.64 1,662.56 2,368.51
Measures the effectiveness ofassets used to produce profits.
Measures the profitibility ofowners investments.
Measures the % of each $1 ofrevenue that is left over asprofit.
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
13/36
= Profit margin 0.3 0.36 0.38 0.43
Total asset turnover Mar'05 Mar'06 Mar'07 Mar'08
Sales 1,007.28 1,291.64 1,662.56 2,368.51
/ Average total assets 2,920.10 3,210.76 3,517.64 4,310.14
= Total asset turnover 0.34 0.4 0.47 0.55
Fixed assets turnover Mar'05 Mar'06 Mar'07 Mar'08
Sales 1,007.28 1291.64 1662.56 2368.51
/ Average fixed assets 439.15 536.19 589.29 630.04
= Fixed asset turnover 2.29 2.41 2.82 3.76
Current asset turnover Mar'05 Mar'06 Mar'07 Mar'08
Sales 1007.28 1291.64 1662.56 2368.51
/ Average current assets 425.6 531.14 679.07 1,468.36
= Current asset turnover 2.37 2.43 2.45 1.61
Mar'05 Mar'06 Mar'07 Mar'08
Net income 305.71 461.29 628.93 1,014.04
/ Average total assets 2,920.10 3,210.76 3,517.64 4,310.14
= Return on investment 10.5% 14.4% 17.9% 23.53
or
Net profit margin 0.3 0.36 0.38 0.43
/ Total asset turnover 0.34 0.40 0.47 0.55
= Return on investment 10.5% 14.4% 17.9% 77.91
Net profit after tax 306 461 629 1,014.04
/ Average stockholders equity 94 94 98 103.56
= Return on equity 324.7% 489.3% 641.3% 979.18
or
Average total assets 2,920 3,211 3,518 4,310.14
/ Average equity 94 94 98 103.56
= Equity mutliplier 31.01 34.06 35.87 41.62
x ROI 10.5% 14.4% 17.9% 23.53
= Return on equity 324.7% 489.3% 641.3% 979.18
Measures the efficiency ofassets used to produce sales.
Measures the efficiency offixed assets used to producesales.
DuPont Return on
Modified DuPont - Return on
Equity
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
14/36
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
15/36
Mar '09
1,186.94
696.34
1.70
Mar'09
20.17
-
680
696.34
1.01
Mar'09
2,774.65
680.03
4.08
Mar'09
365
4.08
89.46
Mar'09
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
16/36
2,774.65
486.74
5.7
Mar'09
365
5.7
64.03
Mar'09
1,186.94
5,175.02
0.23
Mar'09
1,298.18
2.77
468.66
Mar'09
5,175.02
103.56
49.97
Mar'09
1,186.94
5,175.02
0.23
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
17/36
Mar'09
1,186.94
103.56
11.46
Mar'09
719.94
5,151.42
0.14
Mar'09
5,047.86
1,186.94
4.25
Mar'09
1,265.29
1,186.94
1.07
Mar'09
1,265.29
103.56
12.22
Mar'09
570.08
2,774.65
0.21
Mar'09 80.82
2,774.65
0.03
Mar'09
1,265.29
2,774.65
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
18/36
0.46
Mar'09
2,774.65
5,175.02
0.54
Mar'09
2774.65
699.26
3.97
Mar'09
2774.65
1,186.94
2.34
Mar'09
1,265.29
5,175.02
24.45
0.46
0.54
85.05
1,265.29
103.56
1221.8%
5,175.02
104
49.97
2445.0%
1,221.79
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
19/36
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
20/36
NALYSIS OF FINAN
1.LIQUIDITY RATIOS
CURRENT RATIO
Year Mar05 Mar06 Mar07 Mar08
Current Ratio 1.89 1.94 1.97 1.74
The ratio is regarded as a test of liquidity for a company.'working capital' relationship of current assets available tcurrent obligations.Current Ratio = Total Current Assets/ Total Curren
0.5 1 1.5 2 2.5 3 3.5 4 4.5 5
22
2
2
2
2
2
2
2
2
1 2
2 23 2
4 2
Current Ratio
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
21/36
QUICK RATIO
Year Mar05 Mar06 Mar07 Mar08
Quick Ratio 1.06 0.98 1 1.28
0.5 1 1.5 2 2.5 3 3.5 4 4.5 5
1
1
1
1
1
1 12 1 3 1
4 1
Quick Ratio
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
22/36
2.SOLVENCY RATIOS
DEBT-EQUITY RATIO
Year Mar05 Mar06 Mar07 Mar08
D/E Ratio 1.85 1.38 0.58 0.23
DEBT RATIO
0.5 1 1.5 2 2.5 3 3.5 4 4.5
1
1
1
1
1
2
2
21 2
2 1
3 1
4
D/E Ratio
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
23/36
Year Mar05 Mar06 Mar07 Mar08
Debt ratio 0.11 0.7 0.19 0.34
INTEREST COVERAGE RATIOS
Year Mar05 Mar06 Mar07 Mar08
0.5 1 1.5 2 2.5 3 3.5 4 4.5
1
1
1
1
2 1
3
4
Debt ratio
Interest coverage is a financial ratio that provides a quick
companys ability to pay the interest charges on its debt.aspect of the ratio indicates how many times the interestavailable earnings, thereby providing a sense of the safehas for paying its interest for any period.
Ratio=PBIT/total interest expenses
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
24/36
Coverage ratio 0 44.52 73.79 208.94
0.5 1 1.5 2 2.5 3 3.5 4 4.5 5
50
100
150
200
250
300
350
400
450500
12 45
3 74
4 209
5 469
Coverage ratio
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
25/36
IAL RATIOS
3.PROFITABILITY RATIOS
GROSS MARGIN RATIO
Year Mar05 Mar06 Mar07 Mar08
0.32 0.2 0.18 0.26
Mar09
1.7
NET MARGIN
Grossmargin
It expresses themeet the company's
Liabilities
1 2 2 3 3
1
2
3
Gross margin
5.5
2
Current Ratio
This ratio is the percentage of sales dsold and all expenses, except incomecompare your company's "return on scompanies in your industry. It is calcuand tax liabilities vary from companymaking comparisons after taxes mucNet Profit Margin Ratio = Net Profit B
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
26/36
Year Mar05 Mar06 Mar07 Mar08
0.3 0.36 0.38 0.43
Mar09
1.01
Return on Assets Ratio
Year Mar05 Mar06 Mar07 Mar08
ROA 0.99 0.2 0.93 0.69
NETMARGIN
0.5 1 1.5 2 2.5 3
1
23
NET MARGIN
5.5
1Quick Ratio
ROA
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
27/36
Mar09
0.14
RETURN ON INVESTMENT
Year Mar05 Mar06 Mar07 Mar08
ROI 0.99 0.2 0.93 0.69
0.5 1 1.5 2 2.5 3
1
1
1
1
1 1
2
3
INTERPRETATIONBarring first year, has performed well1.1 ratio indicating around more than
5 5.5
5
D/E Ratio
0.5 1 1.5 2 2.5 3
1
1
1
1
1 1
2
3
ROI
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
28/36
Mar09
0.23
Inventory Turnover Ratio
Year Mar05 Mar06 Mar07 Mar08
I.T.R 5.4 4.9 4.99 6.08
D.S.O 67.62 74.44 73.19 60.04
Mar09
4.EFFICIENCY RATIOS
. . .
5 5.5
5
Debt ratio
0 2 4
2
4
6
8
10
12
picture of a
The 'coverage'could be paid fromy margin a company INTERPRETATION
Company is maintaining on an aveultimately has its effect on its cashhigher days outstanding sales in in
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
29/36
468.66
ACCOUNTS RECEIVABLE RATIO
Year Mar05 Mar06 Mar07
A.R.T 4.29 5.04 5.36
D.S.O 85.14 72.47 68.06
5.5
Coverage ratio
0.5 1 1.5 2 2.5 3
20
4060
80
100
120
140
160
180
1 852 72
1 4 2 5
Chart Title
Company has low receivable turnway in different years. But no majo
performance of company in realisiin high collection period. It needs thave far effect on its schedules orrequirements.
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
30/36
Mar09
0.21
4 4 5 5 6
4
5
Gross margin
ollars left after subtracting the Cost of Goodstaxes. It provides a good opportunity toales" with the performance of otherlated before income tax because tax ratesto company for a wide variety of reasons,more difficult.
fore Tax / Net Sales
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
31/36
Mar09
0.46
Mar09
1.07
3.5 4 4.5 5 5.5
45
NET MARGIN
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
32/36
Mar09
1.07
3.5 4 4.5 5 5.5
4 1
5 1ROA
over the last years reaching at a around100% growth on the invested fund.
3.5 4 4.5 5 5.5
1
4 1
5 1
ROI
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
33/36
Mar09
5.7
64.03
. . .
6 8 10 12
age around 5 its conversion ratio whichconversion cycle as it increase a lot due toentory.
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
34/36
Mar08 Mar09
2.24 4.08
162.65 89.46
3.5 4 4.5 5 5.5
3 68
4 163
5 89
3 5 4 2 5 4
A.R.T
D.S.O
ver ratio giving to increase or decreaser improvement is seen indicating poor
g their receivable which is also reflectedwork on its collection policy albeit it willill find itself unable to finance its
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
35/36
SUMMARYCompany has increased its return on assessment as well as the profi
receivable accounts turnover ratio. It needs to work on its collectionreceivable early or lest he will face financial crunch. It also needs toassets to current so as to finance its working capital efficiently
8/8/2019 32 - Akshita - Sun Pharmaceuticals Industries.
36/36
ability but it has very low
olicy so as to realise itsonvert its non-current